c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster (English)
Free access
- New search for: Chung, Elaine Y.
- New search for: Dews, Michael
- New search for: Cozma, Diana
- New search for: Yu, Duonan
- New search for: Wentzel, Erik A.
- New search for: Chang, Tsung-Cheng
- New search for: Schelter, Janell M.
- New search for: Cleary, Michele A.
- New search for: Mendell, Joshua T.
- New search for: Thomas-Tikhonenko, Andrei
- New search for: Chung, Elaine Y.
- New search for: Dews, Michael
- New search for: Cozma, Diana
- New search for: Yu, Duonan
- New search for: Wentzel, Erik A.
- New search for: Chang, Tsung-Cheng
- New search for: Schelter, Janell M.
- New search for: Cleary, Michele A.
- New search for: Mendell, Joshua T.
- New search for: Thomas-Tikhonenko, Andrei
In:
Cancer Biology & Therapy
;
7
, 11
;
1758-1764
;
2008
- Article (Journal) / Electronic Resource
-
Title:c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster
-
Contributors:Chung, Elaine Y. ( author ) / Dews, Michael ( author ) / Cozma, Diana ( author ) / Yu, Duonan ( author ) / Wentzel, Erik A. ( author ) / Chang, Tsung-Cheng ( author ) / Schelter, Janell M. ( author ) / Cleary, Michele A. ( author ) / Mendell, Joshua T. ( author ) / Thomas-Tikhonenko, Andrei ( author )
-
Published in:Cancer Biology & Therapy ; 7, 11 ; 1758-1764
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2008-11-01
-
Size:7 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents – Volume 7, Issue 11
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1705
-
Biochemist Robert Tjian Elected as New Hughes President| 2008
- 1706
-
Wnt signaling and senescence: A tug of war in early neoplasia?Adams, Peter D. / Enders, Greg H. et al. | 2008
- 1712
-
Androgens and epithelial ovarian cancer: What's the connection?Karlan, Beth Y. / Li, Andrew John et al. | 2008
- 1717
-
scFv-Mediated delivery of truncated BID suppresses HER2-positive osteosarcoma growth and metastasisShan, Le-Qun / Qiu, Xiu-Chun / Xu, Yan-Ming / Ji, Zheng-Gang / Yang, Tong-Tao / Chen, Xiang / Ma, Bao-An / Zhou, Yong / Fan, Qing-Yu / Yang, An-Gang et al. | 2008
- 1723
-
Can you tBID on it?Yüksel, Şahru / Özören, Nesrin et al. | 2008
- 1726
-
Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activityFeng, Jian-Ming / Zhu, Hong / Zhang, Xiao-Wei / Ding, Jian / Miao, Ze-Hong et al. | 2008
- 1732
-
Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletionKulawiec, Mariola / Safina, Alfiya F. / Desouki, Mohamed M. / Still, Ivan / Matsui, Sei-Ichi / Bakin, Andrei / Singh, Keshav K et al. | 2008
- 1744
-
In vitro and in vivo antitumor effect of a trivalent bispecific antibody targeting ErbB2 and CD16Lu, Han / Shi, Ming / Wang, Mingli / Xie, Zhigang / Hu, Meiru / Yu, Ming / Shen, Beifen / Ma, Yuanfang / Guo, Ning et al. | 2008
- 1751
-
Nature’s design – a blueprint for engineered therapeutic antibodiesRodeck, Ulrich / Williams, John C. et al. | 2008
- 1753
-
Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell lineHector, Alvarez / Koorstra, Jan-Bart M. / Hong, Seung-Mo / Boonstra, Jurjen J. / Dinjens, Winand N.M. / Foratiere, Arlene A. / Wu, Tsung-Teh / Montgomery, Elizabeth A. / Eshleman, James R. / Maitra, Anirban et al. | 2008
- 1756
-
Cellular biometrics in the postgenomics eraStairs, Douglas B. / Ohashi, Shinya / Nakagawa, Hiroshi et al. | 2008
- 1758
-
c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA clusterChung, Elaine Y. / Dews, Michael / Cozma, Diana / Yu, Duonan / Wentzel, Erik A. / Chang, Tsung-Cheng / Schelter, Janell M. / Cleary, Michele A. / Mendell, Joshua T. / Thomas-Tikhonenko, Andrei et al. | 2008
- 1765
-
Anti colon cancer components from Lebanese sage (Salvia libanotica) essential oil: Mechanistic basisItani, Wafica S. / El-Banna, Sarah H. / Hassan, Saadia B. / Larsson, Rolf L. / Bazarbachi, Ali / Gali-Muhtasib, Hala U. et al. | 2008
- 1774
-
Comedo-Ductal carcinoma in situ: A paradoxical role for programmed cell deathShekhar, Malathy P.V. / Tait, Larry / Pauley, Robert J. / Wu, Gen Sheng / Santner, Steven J. / Nangia-Makker, Pratima / Shekhar, Varun / Nassar, Hind / Visscher, Daniel W. / Heppner, Gloria H. et al. | 2008
- 1783
-
Deficiency of Bloom syndrome helicase activity is radiomimeticHorowitz, David P. / Topaloglu, Ozlem / Zhang, Yonggang / Bunz, Fred et al. | 2008
- 1787
-
Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cellsLi, Lei / Gao, Ye / Zhang, Lin-Lin / He, Da-lin et al. | 2008
- 1793
-
Copy number alterations in pancreatic cancer identify recurrent PAK4 amplificationChen, Shuaili / Auletta, Theresa / Dovirak, Ostap / Hutter, Christina / Kuntz, Karen / El-ftesi, Samyra / Kendall, Jude / Han, Haiyong / Von Hoff, Daniel D. / Ashfaq, Raheela et al. | 2008
- 1803
-
Amplifying Pak kinasesDummler, Bettina / Field, Jeffrey et al. | 2008
- 1806
-
Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinomaMantoni, Tine S. / Schendel, Roy R.E. / Rödel, Franz / Niedobitek, Gerald / Al-Assar, Osama / Masamune, Atsuhi / Brunner, Thomas B. et al. | 2008
- 1816
-
Tumor: Stroma interactions in pancreatic pancer: Will this sparc prove a raging fire?Cengel, Keith A / Edmonds, Christine et al. | 2008
- 1818
-
Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathwaysYu, Hong / Gong, Xiaoqi / Luo, Xunyi / Han, Wei / Hong, Ge / Singh, Baljit / Tang, Careen K. et al. | 2008
- 1829
-
Effect of a novel inhibitory mAb antibody against β-subunit of F1F0 ATPase on HCCWang, Jingbo / Han, Ying / Liang, Jie / Cheng, Xin / Yan, Li / Wang, Yingmei / Liu, Jingmei / Luo, Guanhong / Cheng, Xiong / Zhao, Lina et al. | 2008
- 1836
-
Targeting cell surface F1F0 ATP synthase in cancer therapyMowery, Yvonne M. / Pizzo, Salvatore V. et al. | 2008
- 1839
-
Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approachXing, Yifei / Liu, Mei / Du, Yuefeng / Qu, Feng / Li, Yangsheng / Zhang, Qingwei / Xiao, Yajun / Zhao, Jun / Zeng, Fuqing / Xiao, Chuanguo et al. | 2008
- 1849
-
New insights into the role of CXCR4 in prostate cancer metastasisGladson, Candece L. / Welch, Danny R. et al. | 2008
- 1852
-
An investigation of the effects of nanosize delivery system for antisense oligonucleotide on esophageal squamous cancer cellsLi, Huixiang / Wang, Jin / Zhou, Tianyang / Zhang, Yingge / Zhang, Zhenzhong et al. | 2008
- 1860
-
Nanosize delivery as an emerging platform for cancer therapyLi, Chun-Qi / Zhang, Guang-Xian et al. | 2008
- i
-
Cover Caption| 2008